Trabectedin Completed Phase 3 Trials for Ovarian Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0028213 (Ovarian Cancer)	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT01379989	INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer	Carboplatin (DB00958) Doxorubicin (DB00997) Trabectedin (DB05109)
NCT00113607	An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer	Dexamethasone (DB01234) Doxorubicin (DB00997) Trabectedin (DB05109)